134 related articles for article (PubMed ID: 16640650)
1. Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis.
Teunissen CE; Dijkstra CD; Jasperse B; Barkhof F; Vanderstichele H; Vanmechelen E; Polman CH; Bö L
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):318-31. PubMed ID: 16640650
[TBL] [Abstract][Full Text] [Related]
2. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
Koning N; Bö L; Hoek RM; Huitinga I
Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
[TBL] [Abstract][Full Text] [Related]
4. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
5. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
6. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance.
Gómez M; Hernández ML; Pazos MR; Tolón RM; Romero J; Fernández-Ruiz J
Neuroscience; 2008 May; 153(3):687-99. PubMed ID: 18400407
[TBL] [Abstract][Full Text] [Related]
8. [Axonal damage in multiple sclerosis].
Arbizu-Urdiain T; Martínez-Yélamos A
Rev Neurol; 2000 Jun 16-30; 30(12):1223-7. PubMed ID: 10935255
[TBL] [Abstract][Full Text] [Related]
9. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
10. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis.
Geurts JJ; Wolswijk G; Bö L; van der Valk P; Polman CH; Troost D; Aronica E
Brain; 2003 Aug; 126(Pt 8):1755-66. PubMed ID: 12805104
[TBL] [Abstract][Full Text] [Related]
11. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
[TBL] [Abstract][Full Text] [Related]
12. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
13. [The evidence for primary axonal loss in multiple sclerosis].
Anthony DC; Hughes P; Perry VH
Rev Neurol; 2000 Jun 16-30; 30(12):1203-8. PubMed ID: 10935251
[TBL] [Abstract][Full Text] [Related]
14. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
Wolswijk G; Balesar R
Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
[TBL] [Abstract][Full Text] [Related]
15. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
Fisher E; Chang A; Fox RJ; Tkach JA; Svarovsky T; Nakamura K; Rudick RA; Trapp BD
Ann Neurol; 2007 Sep; 62(3):219-28. PubMed ID: 17427920
[TBL] [Abstract][Full Text] [Related]
16. Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions.
Lu JQ; Fan Y; Mitha AP; Bell R; Metz L; Moore GR; Yong VW
J Neuropathol Exp Neurol; 2009 Feb; 68(2):179-89. PubMed ID: 19151622
[TBL] [Abstract][Full Text] [Related]
17. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
[TBL] [Abstract][Full Text] [Related]
18. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
[TBL] [Abstract][Full Text] [Related]
19. Extensive extracellular matrix depositions in active multiple sclerosis lesions.
van Horssen J; Bö L; Dijkstra CD; de Vries HE
Neurobiol Dis; 2006 Dec; 24(3):484-91. PubMed ID: 17005408
[TBL] [Abstract][Full Text] [Related]
20. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
